The Right Care, in the Right Setting: Rethinking Site of Service in Cardiology

For decades, the hospital has been the default setting for many cardiovascular services. But as technology advances, care models evolve, and healthcare continues its shift toward value, a growing range of diagnostic and procedural services can now be delivered safely and effectively in outpatient settings for appropriately selected patients.

That shift is already underway. Cardiovascular procedures are increasingly moving into ambulatory surgery centers (ASCs), office-based labs (OBLs), and other outpatient settings, driven by:

• Advances in technology, anesthesia, and same-day discharge capabilities
• A more convenient and streamlined patient experience
• Greater physician involvement in care delivery
• The opportunity to reduce total cost of care
• In many cases, lower out-of-pocket costs for patients

The opportunity, however, is not simply to move care out of the hospital.

It is to ensure that every patient receives the right care, in the right setting, at the right time.

Why Site of Service Matters in Value-Based Cardiology

Where care is delivered can materially affect the patient experience, care coordination, clinical outcomes, and the total cost of an episode of care.

Hospitals remain essential for complex procedures, high-risk patients, emergency care, and cases requiring intensive clinical resources. But for appropriate patients and services, a lower-acuity outpatient setting may offer a more efficient and patient-friendly experience without the infrastructure, delays, and complexity often associated with a hospital environment.

This creates a meaningful opportunity within value-based cardiology.

When clinical needs and site of service are thoughtfully aligned, health systems and cardiovascular practices can work toward:

• Improving access, convenience, and timeliness of care
• Reducing unnecessary healthcare spending
• Lowering patient cost-sharing in many cases
• Creating more efficient care pathways
• Increasing physician involvement across the care continuum
• Reserving hospital capacity for patients who truly need it
• Improving the overall patient experience

Site of service is therefore more than an operational decision. It is a core component of managing cardiovascular populations effectively, responsibly, and sustainably.

Cardiovascular Care Is Already Moving Outpatient

The outpatient cardiovascular landscape continues to expand. The number of single-specialty cardiology ASCs in the United States quadrupled between 2018 and 2023, growing from 55 to 221.⁵

Depending on facility capabilities, patient factors, and regulatory requirements, non-hospital settings now support services ranging from diagnostic cardiac catheterization to select percutaneous coronary interventions (PCI), pacemaker procedures, and defibrillator procedures.¹ The American College of Cardiology has developed its CV ASC Registry Suite specifically to measure outcomes and support quality improvement across ASCs, OBLs, and outpatient surgery centers performing these types of cardiovascular procedures.²

Policy is evolving as well. For 2026, CMS expanded the number of procedures eligible for Medicare payment in ambulatory surgical centers and increased physician flexibility in determining the clinically appropriate setting for certain services.³ Cardiac catheter ablation procedures were added to the ASC Covered Procedures List for the first time, and CMS announced plans to phase out the inpatient-only list over the next three years.⁴

These changes reflect a broader evolution in cardiovascular medicine: for appropriately selected patients, the hospital is no longer the only setting capable of delivering high-quality specialty care.

Clinical Appropriateness Must Come First

Lower cost should never be the sole reason to shift a service to an outpatient setting.

A successful site-of-service strategy begins with appropriate patient selection and sound clinical judgment. Clinical complexity, comorbidities, procedural risk, anesthesia requirements, emergency-transfer capabilities, facility resources, and post-procedure needs must all be considered before determining where care should occur.

As cardiovascular procedures continue migrating into outpatient environments, the ACC has emphasized the importance of quality measurement, patient selection, safety standards, regulatory oversight, and consistent outcome tracking across sites of care.¹

The goal is not hospital versus outpatient.

The goal is to build a connected cardiovascular ecosystem in which each setting is used appropriately—and patients receive the level of care their clinical needs require.

The Value Across Stakeholders

For Patients

For appropriate services, outpatient care can offer a simpler and more convenient experience, including less time navigating large hospital campuses, more streamlined scheduling, and a potentially smoother recovery process.

It can also reduce the financial burden of care. Because ASCs and other outpatient facilities may have lower facility charges than hospital outpatient departments, patients may face lower copays, coinsurance, or other out-of-pocket expenses for the same or similar service.

Keeping care closer to a patient’s existing cardiovascular team can also strengthen continuity across diagnosis, procedure, follow-up, and long-term disease management.

For Providers

Outpatient capabilities can give cardiovascular practices greater flexibility in how care is delivered while keeping physicians closely connected to the full patient journey.

For independent practices in particular, thoughtfully designed outpatient strategies may help preserve clinical autonomy while creating more efficient pathways for diagnostics, procedures, recovery, and follow-up care.

For Payers and Health Systems

In a value-based environment, every part of the care continuum matters.

Avoidable utilization, fragmented referrals, duplicated services, and unnecessarily high-cost sites of care can all affect total cost of care.

Aligning appropriate services with the most efficient clinically appropriate setting creates an opportunity to improve the value equation without compromising quality.

For health systems, this also means using hospital resources where they are most needed: for complex, high-acuity, and resource-intensive care, freeing up capacity to do so.

Health system employed cardiology groups can also benefit from the incremental revenue opportunities with value-based care as well and CCA has programs for this.

Quality Has to Follow the Patient

As care expands beyond hospital walls, measurement and accountability must expand with it.

A high-performing outpatient strategy requires the same commitment to quality expected anywhere else in the cardiovascular continuum:

• Standardized clinical pathways
• Appropriate patient selection
• Transparent outcomes reporting
• Clear emergency-transfer protocols
• Reliable follow-up processes
• Continuous performance improvement

National efforts are already moving in this direction. The ACC’s cardiovascular outpatient registry enables participating facilities to benchmark outcomes, monitor adverse events and hospital transfers, and compare performance across similar facilities.²

That infrastructure will become increasingly important as more cardiovascular care moves into new settings.

The Bottom Line

Value-based cardiology asks a different question than traditional fee-for-service medicine.

Not simply, “What service does this patient need?”

But also, “Where can that service be delivered safely, effectively, conveniently, and efficiently?”

Hospitals will always play a critical role in cardiovascular medicine. But they do not need to be the default location for every test, procedure, or episode of care.

By matching clinical needs with the appropriate setting, cardiovascular organizations can improve access, enhance the patient experience, reduce avoidable financial burden for patients, use healthcare resources more efficiently, and lower total cost of care.

Where CCA Comes In

At Cardiac Care Alliance (CCA), we believe the future of cardiovascular care is built around connected, physician-led care pathways that put clinical decision-making first.

Our value-based approach helps cardiology practices look across the full continuum of care—from prevention and chronic disease management to diagnostics, procedures, and ongoing monitoring—to identify opportunities for better coordination, stronger outcomes, and more efficient care delivery.

As outpatient cardiovascular capabilities continue to expand, CCA is focused on helping provider partners evaluate how the right infrastructure, data, care pathways, and site-of-service strategies can support better outcomes while preserving physician autonomy.

Because better value does not come from simply delivering less care. It comes from delivering the right care, in the right setting, at the right time.

To learn more about Cardiac Care Alliance and our physician-led approach to value-based cardiology, contact us at network@cardiaccarealliance.com.

Sources

1. American College of Cardiology. CV Procedures Shifting Into Outpatient Facilities: Key Considerations. July 15, 2025.
2. American College of Cardiology, NCDR. CV ASC Registry Suite: Designed for the Growing Shift to Outpatient Cardiovascular Care.
3. Centers for Medicare & Medicaid Services. Calendar Year 2026 Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Final Rule. November 21, 2025.
4. American College of Cardiology. CMS Releases 2026 Hospital OPPS Final Rule. November 21, 2025.
5. Journal of the American College of Cardiology. Outpatient Migration of Cardiovascular Procedures in the United States. July 2025.

Cardiac Care Alliance Launches Value-Based Cardiology Collaboration with WellMed to Improve Outcomes and Reduce Total Cost of Care 

 

Cardiac Care Alliance (CCA), a physician-led cardiovascular network advancing value-based care, has entered into a comprehensive value-based cardiology collaboration with WellMed Medical Management Inc. part of Optum, a UnitedHealth Group business, effective May 1, 2026. The collaboration, focusing on Medicare Advantage patients, launched in Texas with an initial focus in the Dallas–Fort Worth metroplex and will then expand to additional Texas markets as part of CCA’s broader national payer strategy.

Under the agreement, CCA cardiologists and WellMed primary care physicians align to improve access to care and quality, cardiovascular outcomes, patient and provider experience, and care coordination. The model is designed to reduce unnecessary and preventable hospitalizations and improve medication support.

Cardiovascular disease is a leading driver of morbidity, mortality, and health care spending in the U.S., and traditional fee-for-service models often leave specialty care fragmented. With nearly half of all Medicare beneficiaries choosing a Medicare Advantage plan for their coverage, the CCA and WellMed collaboration embeds cardiology into a more integrated, value-based population health framework for Medicare Advantage enrollees. This approach supports proactive management of cardiovascular disease rather than reactive, episodic care, improving both health outcomes and the total cost of care. With CMS continuing to back specialty-focused value-based arrangements, tighter integration between primary care and cardiology is becoming essential.

 

 

By implementing the innovative CCA model, CCA’s network of cardiologists will:

1. Identify and risk-stratify high-risk cardiovascular patients earlier
2. Improve adherence to evidence-based cardiovascular treatment guidelines
3. Strengthen transitions of care following cardiac events
4. Reduce avoidable emergency department visits and hospital admissions

The collaboration is structured to preserve physician clinical autonomy while aligning incentives around measurable outcomes. By rewarding quality, coordination, and proactive management, the program supports more effective care for complex cardiovascular populations and provides cardiologists with incremental revenue as well.

“I want to thank WellMed for this important collaboration and recognize the entire CCA team as we achieve a critical step in advancing value-based cardiovascular care,” said Prakash Patel, MD, CEO of Cardiac Care Alliance. “By aligning cardiology and primary care around shared objectives as true partners, we can support cardiovascular outcomes in ways that are meaningful for patients and measurable in both quality and cost.”

 

WellMed’s physician-led primary care model emphasizes coordinated, value-based care for Medicare-eligible patients, with a focus on prevention, chronic disease management, and population health. Integrating this model more tightly with specialty cardiology enhances the ability to manage cardiovascular patients across the full continuum of care.

This major milestone underscores the growing role of specialty networks in advancing coordinated, value-based cardiovascular care in Texas and improving outcomes.

About Cardiac Care Alliance

Cardiac Care Alliance is a physician-founded cardiovascular network focused on specialty-driven value-based care. By aligning cardiologists around shared quality metrics, transparent data, and performance-based revenue, CCA integrates specialty care into coordinated health models that improve outcomes and patient and provider experience, while managing total cost of care and sharing incremental value and revenue with participating cardiologists. CCA is expanding its value-based cardiology footprint in key markets across the United States.

Building a Smarter Cardiovascular Ecosystem

Cardiovascular care is no longer defined by isolated encounters or disconnected specialties. As healthcare shifts toward value-based models, success increasingly depends on how well care is coordinated, connected, and aligned across the full continuum.

Cardiovascular disease is projected to reach $1.8 trillion in annual costs by 2035¹, making it one of the most urgent areas for improvement. Yet many of the biggest drivers of cost and poor outcomes are not just clinical. They are operational, driven by how care is delivered, coordinated, and followed through.

Missed handoffs, delayed follow-up care, and disconnected communication between primary care and cardiology often lead to higher utilization, worse outcomes, and avoidable costs.

Why Care Coordination Matters

When care is fragmented, patients are more likely to fall through the cracks. This can show up as:

• Poor communication between care teams

• Delayed handoffs and follow-up care

• Unmanaged risk factors

• Declining medication adherence

• Increased emergency department visits and hospitalizations

In fact, up to 30% of healthcare spending is considered waste², much of it tied to inefficiencies like duplication, delays, and poor coordination.

Stronger care coordination has been shown to improve outcomes, reduce unnecessary utilization, and lower total cost of care, with some programs reducing hospital readmissions by 15–20%³.

In a value-based environment, coordination is not a “nice to have.” It is essential.

---

Connecting Primary Care and Cardiology

A high-functioning cardiovascular ecosystem depends on alignment between primary care providers and cardiologists.

Primary care manages the long-term drivers of cardiovascular risk, while cardiology delivers specialized intervention and disease management. Without coordination, these efforts often operate in parallel rather than in sync.

Better integration enables:

• Earlier identification of at-risk patients

• More seamless referrals and transitions

• Consistent, aligned treatment plans

• Ongoing communication across care teams

When these connections are strong, care becomes more proactive, coordinated, and effective.

---

The Role of Data and Shared Infrastructure

Coordination at scale requires more than intent. It requires infrastructure.

High-performing cardiovascular models are built on a foundation of real-time data, standardized care pathways, and centralized quality reporting. These capabilities allow providers to identify high-risk patients earlier, align treatment approaches, and measure performance consistently across populations.

When paired with care management support between visits, this infrastructure enables a shift from reactive care to proactive population health management, where interventions are timely, targeted, and measurable.

---

The Bottom Line

Better cardiovascular outcomes don’t come from more care. They come from better-connected care.

When primary care and cardiology are aligned and supported by data, infrastructure, and coordination, health systems see fewer avoidable hospitalizations, stronger performance in value-based models, and a lower total cost of care.

---

Where CCA Comes In

At Cardiac Care Alliance (CCA), we are building a physician-aligned cardiovascular network designed to strengthen these connections.

Our model supports:

• Closer alignment between primary care and cardiology

• Data-driven identification of high-risk patients

• Coordinated care across the continuum

• Stronger performance in value-based contracts

All while preserving physician autonomy and independent practice models.

If you’d like to explore how this model can support your organization, contact us at: network@cardiaccarealliance.com

---

Sources

¹ American Heart Association. Heart Disease and Stroke Statistics — 2023 Update. Circulation. 2023;147:e93–e621.
² Institute of Medicine. Best Care at Lower Cost. 2013.
³ Agency for Healthcare Research and Quality (AHRQ). Care Coordination Measures Atlas. Updated 2020.

Empowering Independent Cardiology Practices: A Future Built on Autonomy and Support

Independent cardiology practices play a critical role in delivering accessible, community-based cardiovascular care. Yet many are navigating increasing pressure from rising operating costs, declining reimbursement, hospital consolidation, workforce shortages, and the growing complexity of value-based care programs.

In fact, more than 70% of U.S. physicians now work for hospitals or corporate entities¹, a shift that continues to reshape how care is delivered and raises important questions about the future of physician independence.

At Cardiac Care Alliance (CCA), we believe independence remains both worth protecting and possible to sustain—with the right infrastructure, partnerships, and support models in place.

Why Independence Matters in Cardiology

Independent cardiology practices often deliver meaningful advantages for patients, providers, and payers alike, including:

• Lower total cost of care for patients and payers²
• Greater accessibility and continuity of care
• More nimble decision-making and faster clinical innovation
• Care that is deeply rooted in community needs
• Clinical autonomy centered on the physician–patient relationship

However, independence does not mean practices must operate in isolation. As care delivery and payment models evolve, collaborative support structures have become increasingly essential.

How CCA Strengthens Independent Cardiology Practices

Cardiac Care Alliance is a physician-led, cardiology-focused clinically integrated network (CIN) designed to help practices thrive in a value-based environment—without sacrificing ownership or autonomy.

Incremental Revenue and Ancillary Expansion

Independent practices operate in a healthcare system where scale and centralized expertise are increasingly important for accessing new revenue opportunities. CCA helps practices unlock value through:

• Shared savings from value-based care contracts
• Expanded ancillary services, including RPM, CCM, cardiac rehab, clinical research, PET-CT, imaging, diagnostics, and monitoring services
• Site-of-service optimization, including office-based procedures, OBL alignment, and ASC strategies

These opportunities support financial stability while preserving full practice ownership.

Higher Value-Based and Population Health Performance

CCA provides the infrastructure needed to support performance under Medicare Advantage and emerging CMS programs by strengthening:

• Cardiovascular quality measure performance
• Medication adherence
• Risk adjustment accuracy
• Care coordination
• Early identification and management of high-risk patients
• Reduction of avoidable emergency department visits and hospital admissions

When outcomes and cost efficiency improve together, long-term independence becomes more sustainable.

A Clinically Integrated Network Built for Cardiologists

CCA is intentionally structured to enhance independence—not replace it. Participating practices maintain:

• Full ownership
• Independent branding
• Complete clinical autonomy

Unlike traditional CIN or MSO models, CCA does not acquire practices or direct-staffing. Instead, we augment cardiology teams with critical resources that strengthen performance while preserving physician-led decision-making.

Operational Support That Reduces Administrative Burden

CCA delivers operational infrastructure that strengthens the foundation around the practice, including:

• Cardiology-focused analytics
• 24/7 care management for high-risk patients
• Centralized quality reporting
• Contracting and payer alignment

This support allows physicians and care teams to focus more on delivering high-quality care—and less on administrative complexity.

The Bottom Line

Independence in cardiology is achievable, but it requires infrastructure, collaboration, and the ability to perform in value-based care models.

CCA helps build that foundation, empowering cardiology practices to remain autonomous while achieving stronger clinical outcomes, improved operational performance, and meaningful new revenue opportunities.

If you’d like to explore whether this model aligns with your practice’s goals, we’d be happy to connect at network@cardiaccarealliance.com.

Sources

¹ American Medical Association. 2022 Physician Practice Benchmark Survey. Published 2023.
² Health Care Cost Institute. 2018–2022 Health Care Cost and Utilization Reports.

AI in Cardiology: From Detection to Value-Based Impact

Artificial intelligence (AI) is transforming how clinicians identify, understand, and manage heart disease—often before symptoms appear. As AI tools move from pilots to routine use, the key question is no longer if AI will reshape cardiology, but how these tools will improve outcomes for patients, support providers, and strengthen value-based care models.

Cardiovascular disease (CVD) remains the leading driver of healthcare costs and preventable mortality. Yet many heart attacks occur in individuals previously labeled “low-risk.” AI offers a promising opportunity to close this gap by identifying early disease signals—such as vulnerable plaque, subtle perfusion defects, or silent ischemia—long before they progress to clinical events.

Studies suggest that up to 80% of cardiovascular events may be preventable through early detection and intervention (American Heart Association, 2023). AI-enabled CCTA (coronary CT angiography) strengthens that approach by helping clinicians detect plaque earlier and reduce unnecessary invasive procedures, including diagnostic catheterizations. The result: improved outcomes, reduced system waste, and more efficient care pathways.

How AI Creates Real Clinical Value

1. Seamless Integration Into Care: To be impactful, AI must integrate directly into imaging systems, electronic health records (EHRs), and care-coordination workflows. When AI fits naturally into existing processes, clinicians can access results quickly without adding complexity.
2. Earlier Risk Insight: AI enhances clinicians’ ability to recognize risk sooner and with greater precision. This enables proactive management and targeted preventative strategies—critical elements of value-based cardiology.
3. Clinical Transparency & Trust: For widespread adoption, AI outputs must be easy to interpret and clinically validated. Clear thresholds, performance data, and reproducibility help clinicians build confidence in the technology.
4. Alignment with Value-Based Payment Models: Prevention and early detection should be rewarded—not overlooked. When early identification helps avoid an unnecessary catheterization or unplanned readmission, those savings flow directly into shared-savings models. This strengthens financial sustainability while improving patient experience.

What This Means for Key Stakeholders

• Providers & Health Systems:
  • Health systems evaluating AI should look beyond accuracy alone. Workflow fit, turnaround time, and downstream usability matter just as much. Pilot programs can help measure real-world impact—such as adherence, avoided events, and more personalized care pathways. Multidisciplinary collaboration across radiology, cardiology, and primary care ensures shared ownership and stronger implementation.
• Providers & Health Systems:
  • As AI moves into mainstream cardiology, payer strategies must evolve. Incentives should support early intervention and prevention. Transparent reporting on sensitivity, specificity, and bias reduction helps ensure equitable, reliable care. AI-enabled risk tiers also allow more proactive care management and improved population-health performance.
• Patients & Communities:
  • Early detection creates more time to act, but only when paired with strong follow-up care, lifestyle support, and consistent management.

Imagine a 65-year-old patient whose “silent” plaque was caught early—before it became an emergency room visit. That’s the promise of AI in cardiology: empowering care teams to act sooner, intervene smarter, and prevent avoidable events.

Industry Trends to Watch

• Growth in real-world data from AI-enabled cardiovascular detection programs

• Policy and reimbursement updates affecting AI diagnostics

• New entrants in cardiovascular AI—and how they measure up on validation, integration, and clinical adoption

CCA + Cleerly: A Collaborative Step Forward

Earlier this year, Cardiac Care Alliance partnered with Cleerly to implement AI-driven heart-disease detection within value-based cardiology programs. The collaboration aims to reduce avoidable diagnostic catheterizations—one of the key levers for improving outcomes while lowering costs.

Read the announcement → https://cardiaccarealliance.com/cleerly-and-cardiac-care-alliance-join-forces/

Conclusion

AI is rapidly becoming an essential tool in cardiology—helping clinicians detect disease earlier, improve care pathways, and strengthen the financial and clinical foundations of value-based care. When combined with thoughtful implementation, transparent data, and patient-centered follow-up, AI has the potential to reshape cardiovascular care for the better.

Coronary Calcium Scoring: The Simple Test Guiding Smarter Heart Prevention

In heart health, the challenge isn’t a lack of data — it’s knowing how to turn that data into action. One of the most powerful, yet often overlooked, tools in heart disease prevention is coronary artery calcium (CAC) scoring.

At Cardiac Care Alliance (CCA), we believe prevention works best when it’s precise, guided by data, and easy for patients to understand. CAC scoring helps doctors and patients take a closer look at heart health before symptoms start, allowing for more personalized care, smarter prevention, and better long-term outcomes.

In this article, we’ll explore:

1. What CAC scoring is and how it helps doctors understand heart disease risk
2. Who should get scanned, and why
3. How CAC testing fits into prevention and long-term care

1. How CAC Scores Reclassify Risk

A CAC score measures the amount of calcium (plaque) in the heart’s arteries. The more calcium that’s present, the higher the chance of developing heart disease in the future.

In simple terms, a low score means a low chance of heart problems, while a high score signals a greater risk. For many people, it helps take the guesswork out of whether medication, like a statin, or more intensive lifestyle changes might be needed.

By combining CAC results with traditional risk factors, such as age, blood pressure, and cholesterol, doctors get a clearer, more personalized view of your heart health.

For patients, these test results can be eye-opening. Someone who thought they were at low or moderate risk might discover hidden plaque that signals a higher likelihood of heart disease — prompting earlier action, more frequent monitoring, or targeted treatment. Likewise, patients with a CAC score of zero can gain peace of mind and focus on maintaining healthy habits. CAC testing helps both patients and clinicians make more confident, individualized decisions about prevention.

2. Who Should Get Scanned — and Why

CAC testing is most useful for adults with no symptoms of heart disease who might be wondering, “Am I at risk?”

If you’re between 40 and 70 years old, have risk factors such as high cholesterol, diabetes, or a family history of heart disease — but you’re not sure whether you need to start treatment — this scan can help provide answers.

Think of it this way:

• If your CAC score is zero, your arteries show no calcium buildup, which means your short-term risk for a heart event is very low.
• If your score is moderate or high, your doctor may suggest earlier or more aggressive prevention through medication, diet, or lifestyle changes.

This test is quick, noninvasive, and takes only a few minutes, but the results can make a major difference in your long-term heart health.

How CAC Supports Prevention and Care Planning 

For health systems and payers, CAC is a valuable tool because it helps focus care where it matters most. Instead of using a one-size-fits-all approach, CAC allows care teams to identify who truly needs treatment and who might safely delay it.

From a cost perspective, research shows that CAC-guided prevention can reduce unnecessary medications and downstream procedures, saving money while improving outcomes.

By identifying high-risk individuals earlier, CAC supports the foundation of value-based care: preventing costly complications before they occur. When patients at elevated risk are identified sooner, interventions can be tailored, monitored, and measured — leading to improved outcomes, better use of resources, and reduced hospitalizations. This proactive approach is central to how CCA partners with health systems and payers to drive value across cardiovascular care.

And while insurance coverage for CAC testing varies, advocacy is growing for including it as part of broader preventive care programs.

The Bottom Line

Coronary calcium scoring is more than a number, it’s a new way to view risk differently. It empowers both clinicians and patients to take preventive action earlier, more confidently, and more efficiently.

Meaningful change happens when health systems, providers, and payers work together to make prevention a priority. That’s why at Cardiac Care Alliance, we’re committed to advancing data-driven, value-based solutions that transform cardiovascular prevention and care delivery across the nation.

If your organization or network is exploring how to integrate CAC scoring or other preventive diagnostics into value-based cardiovascular care models, let’s connect. Learn how CCA partners with health systems, providers, and payers to improve outcomes and optimize cardiovascular care through collaboration.

The Rise of GLP-1 Agonists in Cardiovascular Care

For years, GLP-1 medications like Ozempic, Wegovy, and Trulicity have dominated headlines for their impact on weight loss. But beyond the before-and-after photos, something far more important is happening: these drugs are showing benefits for heart health.

In fact, GLP-1s may represent one of the most promising developments in cardiometabolic medicine in decades, and they’re reshaping how providers think about prevention, risk management, and long-term outcomes.

Beyond the Scale: Protecting the Heart

GLP-1 receptor agonists were originally designed to improve blood sugar control in type 2 diabetes, but clinical trials also revealed additional cardiovascular benefits:

• The LEADER trial (liraglutide): Found a 13% reduction in major adverse cardiovascular events (MACE) in high-risk patients with diabetes.
• The SUSTAIN-6 trial (semaglutide): Showed a 26% reduction in cardiovascular death, non-fatal heart attack, or stroke.
• The SELECT trial: Demonstrated semaglutide reduced cardiovascular events in patients with established cardiovascular disease but without diabetes.
• The STEP-HFpEF trial: Found improvements in symptoms and fewer hospitalizations for patients with obesity-related heart failure with preserved ejection fraction (HFpEF) — but it’s important to note that results should not be generalized to all heart failure patients.

These findings confirm what providers are seeing in practice: GLP-1s don’t just help patients lose weight, they can also protect the heart in carefully selected populations.

What This Means for Patients

For patients with obesity, diabetes, or established cardiovascular disease, GLP-1s may offer:

• Lower risk of cardiovascular events like heart attack or stroke
• Improved quality of life through weight loss, blood pressure control, and better cholesterol management
• Hope for symptom relief in obesity-related HFpEF

Still, these medications are not for everyone. GLP-1s can be costly, require careful monitoring, and work best when integrated into an overall care plan that considers long-term value, patient adherence, and safety.

GLP-1s and the Future of Value-Based Cardiology

While cardiologists are unlikely to prescribe GLP-1s to every patient, these medications are increasingly viewed as a potential component of comprehensive, value-based cardiometabolic care. For providers, this means:

• Staying informed about evolving clinical trial data and guideline updates
• Collaborating with endocrinologists and primary care physicians on appropriate prescribing
• Educating patients about realistic expectations, cost considerations, and potential side effects
• Ensuring any use fits into value-based, patient-centered care models

How CCA Sees the Future

At Cardiac Care Alliance, we view the rise of GLP-1s as part of a broader shift: cardiovascular care is becoming more preventive, more holistic, and more connected than ever before. CCA is exploring how GLP-1s may fit into comprehensive cardiometabolic care models. This ensures that if and when these therapies are incorporated, they’re used appropriately, cost-effectively, and in alignment with value-based care.

Because at the end of the day, innovation only matters if it truly reaches the patients who need it most.

Interested in learning more? Contact Us to explore how CCA supports cardiologists and health systems in advancing smarter cardiovascular care.

Remote Patient Monitoring: Reducing Hospitalizations for Heart Failure

Heart failure (HF) is one of the most common, and costly, chronic conditions in the United States. HF continues to place a significant burden on patients, providers, and the healthcare system. Beyond the clinical challenges, the financial and human costs are staggering:

• Heart Failure accounts for nearly 1 million hospitalizations annually and is a leading driver of Medicare spending.
• HF ranks among the most expensive inpatient diagnoses, with hospitalizations alone costing an estimated $18.5 billion each year.
• Research from the Agency for Healthcare Research and Quality (AHRQ) shows that HF is one of the top conditions driving frequent hospital readmissions among Medicare patients.

For patients, each hospitalization can mark a setback in their health, quality of life, and independence.

That’s why remote patient monitoring (RPM) has emerged as a powerful tool in value-based cardiovascular care. In fact, clinical studies have demonstrated that remote monitoring can reduce heart failure hospitalizations by 37% – as shown in the CHAMPION Trial.

By aligning clinical impact with financial performance, RPM becomes a cornerstone of value-based cardiology.

At Cardiac Care Alliance (CCA), we partner with independent cardiologists and health systems to integrate remote patient monitoring into care models that improve outcomes while reducing costs. This delivers measurable value to patients, providers, and payers alike.

Best Practices for Integrating Remote Patient Monitoring into Heart Failure Care

1. Identify the Right Patients:
   RPM is most effective when targeted to high-risk patients: those with advanced HF, recent hospitalizations, or difficulty managing symptoms. Using data-driven risk stratification ensures resources are focused where they have the most impact.
2. Establish Clear Clinical Protocols:
   Technology is only as good as the workflows behind it. RPM programs should define thresholds for alerts, escalation processes, and follow-up protocols to ensure timely action when patient data indicates a change in status.
3. Empower Patients with Education:
   Remote monitoring is most successful when patients understand why it matters. Education on device use, symptom awareness, and when to reach out to the care team increases adherence and engagement.
4. Integrate with Care Teams:
   RPM data should feed directly into the patient’s care plan, enabling seamless coordination between cardiologists, primary care providers, nurses, and other specialists. At CCA, we help practices connect RPM platforms with EHR systems and population health tools for a unified view of the patient.

The Value Across Stakeholders

For Patients

• Fewer hospital stays: Interventions happen earlier, before symptoms worsen.
• Improved quality of life: More days at home, fewer in the hospital.
• Empowerment: Patients take a more active role in managing their condition.

For Providers

• Better outcomes: Proactive care means fewer acute episodes and readmissions.
• Operational efficiency: Data-driven workflows reduce unnecessary visits while prioritizing patients who need immediate attention.
• Value-based success: Stronger performance on quality measures leads to improved reimbursement under value-based contracts.

For Payers

• Cost savings: Fewer hospitalizations reduce total spend per member.
• Member satisfaction: Healthier patients mean higher satisfaction and retention.
• Performance alignment: RPM supports broader population health and risk-based contract goals.

RPM as a Cornerstone of Value-Based Cardiology

Remote patient monitoring is not just a technology investment – it’s a strategic tool in redesigning how we deliver heart failure care. By combining real-time patient data with proactive, coordinated care models, RPM addresses the triple aim of healthcare: better outcomes, lower costs, and improved patient experience.

Proven Reductions in heart failure hospitalizations not only improve patient outcomes but also directly support value-based care success metrics, including:

• 30-day readmission rates
• Emergency department visits
• Medication adherence
• Per-member-per-month (PMPM) savings

At Cardiac Care Alliance, we design RPM programs that are practical, scalable, and aligned with value-based care goals. From contract negotiation to workflow design and quality performance tracking, we ensure RPM becomes an integrated, high-impact part of your value-based care strategy.

Want to learn how RPM can help reduce hospitalizations and improve heart failure care in your organization?

Contact us to explore how we can support your transformation toward smarter, outcomes-driven cardiology.

As the U.S. healthcare system continues its shift from volume to value, cardiology stands at the forefront of this transformation. Cardiovascular disease remains the leading cause of death and is also one of the most costly and complex conditions to treat, accounting for nearly one-third of total Medicare spending. That’s why more cardiology practices, payers, and health systems are embracing value-based care (VBC): a smarter, outcomes-driven model that prioritizes prevention, coordinated care, and long-term impact over fee-for-service transactions.

At Cardiac Care Alliance (CCA), we believe that redefining heart care starts with realigning incentives around what matters most: improved outcomes, better patient experiences, and sustainable growth for providers. Through our national network of independent cardiologists and payer partners, we’re building scalable, value-based solutions that are transforming how cardiovascular care is delivered, measured, and experienced.

---

What Is Value-Based Care in Cardiology?

At its core, value-based care (VBC) redefines how success is measured in healthcare. Rather than rewarding the quantity of services provided, this model emphasizes the quality of care and the outcomes that matter most to patients. In cardiology, a field often burdened by fragmented care pathways and costly interventions, value-based care introduces a framework built on accountability, evidence-based practices, and long-term patient benefit.

Key Components of Value-Based Cardiology Models:

1. Risk Stratification & Proactive Management: Identifying high-risk patients early and managing them with preventive care strategies is critical. VBC models rely on data to stratify risk and prioritize early intervention, especially in heart failure, hypertension, and coronary artery disease.
2. Care Coordination & Integration: Seamless collaboration between cardiologists, primary care providers, and ancillary services ensures that patients receive the right care at the right time. This reduces duplicative testing, enhances medication adherence, and lowers the risk of readmission.
3. Performance-Based Metrics: Clinical outcomes, patient satisfaction, and efficiency metrics (such as hospitalizations avoided) are tracked and tied to reimbursement. Transparency and accountability are essential components of value-based care models.
4. Patient Engagement: Empowering patients with tools like remote monitoring, care plans, and education improves adherence and self-management, all leading to better health outcomes and fewer acute episodes.

---

The Impact: Lower Costs, Better Outcomes, Happier Patients

The traditional fee-for-service model incentivizes volume, not value. This often results in over-utilization, especially in cardiology, where cath lab referrals, imaging, and hospital stays can quickly escalate costs.

By contrast, value-based cardiology models deliver measurable benefits:

• Cost Savings: Studies show that coordinated, preventive cardiovascular care reduces hospital admissions, readmissions, and unnecessary procedures.
• Improved Outcomes: Value-based care models drive earlier diagnosis and better chronic disease management, especially for conditions like heart failure and clogged arteries.
• Enhanced Patient Experience: With a focus on continuity, communication, and prevention, patients feel more supported and more in control of their health journey.

---

How Cardiac Care Alliance Supports Value-Based Transformation

At CCA, we understand the complex realities cardiologists face: shrinking reimbursements, rising overhead, and increasing pressure to adopt new care models. That’s why we built a framework specifically designed to help independent cardiology practices thrive in a value-based ecosystem.

Here’s how we help:

1. Infrastructure & Analytics: We provide the digital tools and data platforms cardiologists need to track performance, stratify risk, and manage patient populations proactively. Our analytics tools support transparency and make it easier to meet quality benchmarks.
2. Contracting & Payer Alignment: CCA handles value-based contracts and administrative complexities so practices can stay focused on patient care. We work closely with payers to align incentives, reduce friction, and ensure providers are rewarded for delivering high-quality, cost-effective care.
3. Incremental Revenue for Proactive Care & Quality Performance: We help providers gain incremental revenue through proactive care management programs such as Chronic Care Management (CCM), Remote Patient Monitoring (RPM), and virtual cardiac rehab. Additionally, we build strategies that reward closure of care gaps and improved performance on quality measures, helping practices increase revenue while improving patient outcomes.
4. Care Model Design & Support: CCA helps practices adopt scalable solutions that fit their unique needs. We offer coaching, training, and operational playbooks to drive long-term success in value-based arrangements.
5. Future Readiness: We position practices for success under upcoming CMS initiatives like the Ambulatory Specialty Care Models, which will tie payment directly to performance on outcomes for conditions such as heart failure.
6. Preserving Autonomy: Most importantly, we believe cardiologists should remain at the center of care. We support independent practices without taking over. Providers maintain their brand, voice, and clinical leadership while gaining access to a national support network. Learn more about how we support independent cardiologists here.

---

The Road Ahead

Cardiovascular disease remains the leading cause of death in the U.S., but too often, care is reactive, fragmented, and driven by outdated incentives. Value-based cardiology is changing that. It’s creating a smarter, more sustainable model that puts outcomes over output, patients over procedures.

As we continue to grow our national network of aligned, independent providers, Cardiac Care Alliance is committed to being a catalyst for this change. Together, we’re proving that heart care can be more connected, more efficient, and more compassionate, all without sacrificing autonomy or quality.

 

Advancing Cardiovascular Care in California: Welcoming Radiant Medical Group to Cardiac Care Alliance

At Cardiac Care Alliance (CCA), we believe that cardiovascular care can and should be smarter, more connected, and rooted in physician leadership. Today, we’re proud to announce a partnership that reflects those very ideals.

Radiant Medical Group, a leading cardiology and primary care provider based in California, has joined the CCA network. With an unwavering commitment to delivering high-quality, patient-centered care, Radiant brings deep expertise in cardiovascular services and a shared vision for transforming how care is delivered across the state.

This collaboration strengthens our growing network of independent providers who are redefining what’s possible in value-based cardiology.

“Our practice has always believed in the power of personalized, evidence-based care, and in the importance of keeping cardiologists at the center of that process. Partnering with CCA gives us access to the tools, infrastructure, and national support needed to grow our impact while staying true to our mission.  — Dr. Venkat Devineni, MD, FACC, Cardiologist, Radiant Medical Group

Why This Partnership Matters

Cardiovascular disease remains the leading cause of death in the U.S., and yet, the system for treating it is fragmented and reactive. At CCA, we’re building something different: a physician-aligned model that supports prevention, early intervention, and coordinated care across the entire patient journey.

With Radiant Medical Group, we’re expanding this model into new communities throughout California, providing access to:

• Comprehensive, team-based cardiovascular care
• Streamlined care coordination between primary care and specialty providers
• Scalable, value-based solutions that reduce unnecessary procedures and improve outcomes
• Operational support through CCA’s national MSO infrastructure

Together, we are creating a connected, outcomes-driven network that empowers physicians and puts patients first.

Empowering Independent Cardiologists

Radiant’s partnership with CCA represents more than geographic expansion. It reinforces our shared belief that independence and innovation can go hand in hand. Through this collaboration, Radiant’s providers gain access to enhanced practice support while maintaining clinical autonomy and local brand identity.

This is the model we’re scaling across the country: independent cardiologists, working collaboratively, supported by shared infrastructure and aligned on delivering measurable value in heart health.

Building the Future, Practice by Practice

As we welcome Radiant Medical Group to the CCA network, we also recognize the momentum this represents. Following recent partnerships with Cardiovascular Value Partners and West Texas Heart & Vascular, this marks another step toward our goal of building a national, value-based cardiovascular network rooted in physician leadership and high-quality, community-focused care.

We’re excited to work alongside Dr. Devineni and the Radiant team to deliver meaningful change — for patients, providers, and communities across California and beyond.